EICHORCondition: Chronic Lymphocytic Leukemia · Non Hodgkin Lymphoma · Sponsor: TG Therapeutics, Inc.
This is an open label compassionate use trial of Ublituximab and TGR-1202 in combination or as single agents in patients currently receiving treatment on Ublituximab and/or TGR-1202 trials with B-cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Subjects must be currently receiving treatment with ublituximab and/or TGR-1202 on a previously approved protocol. * Subjects must have completed at least 6 cycles of therapy on their current protocol. Exclusion Criteria: * Subject progressed while receiving therapy with ublituximab and/or TGR-1202 while participating in their immediate previous trial.
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| TG Therapeutics Investigational Trial Site | Huntsville, Alabama, United States | — |
| TG Therapeutics Investigational Trial Site | Tucson, Arizona, United States | — |
| TG Therapeutics Investigational Trial Site | Fayetteville, Arkansas, United States | — |
| TG Therapeutics Investigational Trial Site | Duarte, California, United States | — |
| TG Therapeutics Investigational Trial Site | Fort Myers, Florida, United States | — |
| TG Therapeutics Investigational Trial Site | Atlanta, Georgia, United States | — |
| TG Therapeutics Investigational Trial Site | Fort Wayne, Indiana, United States | — |
| TG Therapeutics Investigational Trial Site | Coon Rapids, Minnesota, United States | — |
| TG Therapeutics Investigational Trial Site | Omaha, Nebraska, United States | — |
| TG Therapeutics Investigational Trial Site | Durham, North Carolina, United States | — |
| TG Therapeutics Investigational Site | Canton, Ohio, United States | — |
| TG Therapeutics Investigational Trial Site | Cincinnati, Ohio, United States | — |
+ 5 more locations — full list on the registry record.
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03207256